APPLICATION
NDA209862
TYPE
NDA
ORIGINAL APPROVAL
2016-10-19
LATEST ACTION
2016-10-19
ROUTE
INTRAMUSCULAR, SUBCUTANEOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
EVZIO (AUTOINJECTOR) · ReferenceDiscontinued
NALOXONE HYDROCHLORIDE 2MG/0.4ML (2MG/0.4ML) · SOLUTION · INTRAMUSCULAR, SUBCUTANEOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.